(PharmaNewsWire.Com, September 29, 2017 ) According to the report Middle East and Africa Tumor Ablation Market, published by Market Data Forecast the Market was worth USD 37.50 million in 2016 and estimated to be growing at a CAGR of 11.66%, to reach USD 65.10 million by 2021. Tumors are the group of abnormal cells that accumulate together and form lumps. Tumor ablation is a minimally invasive procedure which is used to destroy cancer cells in the chest, lung and liver.
Rising Prevalence of cancer is proportional to the growth of tumor ablation market. According to the recent statistics published by the WHO, cancer accounts for 13% of the deaths worldwide. Cancer incidence is expected to increase by 70% over the next couple of decades.
Middle-East & Africa tumor ablation market is driven by factors such as growing aging population and increasing number of people affected with cancer. Increasing demand for minimally invasive cancer treatment procedures and growing awareness about the benefits offered by ablation procedures over the conventional surgical procedures are also some of the key factors adding up to growth of the market. However key challenges related to ablation procedures and strict regulatory guidelines are hindering the growth of the market.
Middle-East & Africa tumor ablation market is segmented by technology, treatment and application. Based on technology the market is sub-segmented as Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices and other Ablation Devices. Radiofrequency devices are the dominating technology segment accounting for a share of approximately 35% attributed to its vital role in solid tumour removal in the body. On the basis of treatment the market is segmented as Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Surgical Procedures segment accounted for a prominent share of around 37% owing to increasing prevalence of liver and breast cancers. By application Middle-East & Africa tumor ablation market is segmented as Liver Cancer, Breast Cancer, Lung Cancer, Prostrate Metastasis and other cancer. Based on geography Middle-East & Africa Tumor Ablation market is segmented into Middle-East and Africa. Middle-East accounted for the largest share of the market due to high disposable income and wide spread awareness about various ablation procedures where as Africa is estimated to be the fastest growing region due to high prevalence of the disease in the region.
Some of the key companies dominating the market include Medtronic Plc., Boston Scientific Corporation, Galil Medical Inc., Angiodynamics, Mermaid Medical, HealthTronics, EDAP TMS S.A., SonaCare Medical, Misonix, Inc. and Neuwave Medical, Inc.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
